Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Saved in:
| Title: | Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021. |
|---|---|
| Authors: | Kissling E; Epiconcept, Paris, France., Hooiveld M; Nivel, Utrecht, the Netherlands., Sandonis Martín V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Martínez-Baz I; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., William N; Public Health Scotland, Glasgow, Scotland., Vilcu AM; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Royal College of General Practitioners Research and Surveillance Centre, London, UK., Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Machado A; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Brytting M; The Public Health Agency of Sweden, Stockholm, Sweden., Casado I; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Murray JK; Public Health Scotland, Glasgow, Scotland., Belhillil S; Unité de Génétique Moléculaire des Virus à ARN, UMR 3569 CNRS, Université Paris Diderot SPC, Institut Pasteur, Paris, France.; CNR des virus des infections respiratoires, Institut Pasteur, Paris, France., Larrauri A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Tsang R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Royal College of General Practitioners Research and Surveillance Centre, London, UK., de Lange M; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Riess M; The Public Health Agency of Sweden, Stockholm, Sweden., Castilla J; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Hamilton M; Public Health Scotland, Glasgow, Scotland., Falchi A; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France., Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Dunford L; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Cogdale J; Public Health England, London, England., Jansen T; Nivel, Utrecht, the Netherlands., Guiomar R; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Enkirch T; The Public Health Agency of Sweden, Stockholm, Sweden., Burgui C; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Sigerson D; Public Health Scotland, Glasgow, Scotland., Blanchon T; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Martínez Ochoa EM; Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública, Consumo y Cuidados, La Rioja, Spain., Connell J; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Ellis J; Public Health England, London, England., van Gageldonk-Lafeber R; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Kislaya I; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Rose AM; Epiconcept, Paris, France., Valenciano M; Epiconcept, Paris, France. |
| Corporate Authors: | I-MOVE-COVID-19 primary care study team; The members of the I-MOVE-COVID-19 primary care study team are listed in the Investigators tab., I-MOVE-COVID-19 primary care study team (in addition to authors above) |
| Source: | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2021 Jul; Vol. 26 (29). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34296676 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kissling+E%22">Kissling E</searchLink>; Epiconcept, Paris, France.<br /><searchLink fieldCode="AU" term="%22Hooiveld+M%22">Hooiveld M</searchLink>; Nivel, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Sandonis+Martín+V%22">Sandonis Martín V</searchLink>; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-Baz+I%22">Martínez-Baz I</searchLink>; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22William+N%22">William N</searchLink>; Public Health Scotland, Glasgow, Scotland.<br /><searchLink fieldCode="AU" term="%22Vilcu+AM%22">Vilcu AM</searchLink>; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.<br /><searchLink fieldCode="AU" term="%22Mazagatos+C%22">Mazagatos C</searchLink>; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Domegan+L%22">Domegan L</searchLink>; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22de+Lusignan+S%22">de Lusignan S</searchLink>; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Royal College of General Practitioners Research and Surveillance Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Meijer+A%22">Meijer A</searchLink>; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Machado+A%22">Machado A</searchLink>; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Brytting+M%22">Brytting M</searchLink>; The Public Health Agency of Sweden, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Casado+I%22">Casado I</searchLink>; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Murray+JK%22">Murray JK</searchLink>; Public Health Scotland, Glasgow, Scotland.<br /><searchLink fieldCode="AU" term="%22Belhillil+S%22">Belhillil S</searchLink>; Unité de Génétique Moléculaire des Virus à ARN, UMR 3569 CNRS, Université Paris Diderot SPC, Institut Pasteur, Paris, France.; CNR des virus des infections respiratoires, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22Larrauri+A%22">Larrauri A</searchLink>; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22O'Donnell+J%22">O'Donnell J</searchLink>; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Tsang+R%22">Tsang R</searchLink>; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.; Royal College of General Practitioners Research and Surveillance Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22de+Lange+M%22">de Lange M</searchLink>; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rodrigues+AP%22">Rodrigues AP</searchLink>; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Riess+M%22">Riess M</searchLink>; The Public Health Agency of Sweden, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Castilla+J%22">Castilla J</searchLink>; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Hamilton+M%22">Hamilton M</searchLink>; Public Health Scotland, Glasgow, Scotland.<br /><searchLink fieldCode="AU" term="%22Falchi+A%22">Falchi A</searchLink>; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France.<br /><searchLink fieldCode="AU" term="%22Pozo+F%22">Pozo F</searchLink>; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Dunford+L%22">Dunford L</searchLink>; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Cogdale+J%22">Cogdale J</searchLink>; Public Health England, London, England.<br /><searchLink fieldCode="AU" term="%22Jansen+T%22">Jansen T</searchLink>; Nivel, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Guiomar+R%22">Guiomar R</searchLink>; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Enkirch+T%22">Enkirch T</searchLink>; The Public Health Agency of Sweden, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Burgui+C%22">Burgui C</searchLink>; Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sigerson+D%22">Sigerson D</searchLink>; Public Health Scotland, Glasgow, Scotland.<br /><searchLink fieldCode="AU" term="%22Blanchon+T%22">Blanchon T</searchLink>; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.<br /><searchLink fieldCode="AU" term="%22Martínez+Ochoa+EM%22">Martínez Ochoa EM</searchLink>; Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública, Consumo y Cuidados, La Rioja, Spain.<br /><searchLink fieldCode="AU" term="%22Connell+J%22">Connell J</searchLink>; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Ellis+J%22">Ellis J</searchLink>; Public Health England, London, England.<br /><searchLink fieldCode="AU" term="%22van+Gageldonk-Lafeber+R%22">van Gageldonk-Lafeber R</searchLink>; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kislaya+I%22">Kislaya I</searchLink>; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Rose+AM%22">Rose AM</searchLink>; Epiconcept, Paris, France.<br /><searchLink fieldCode="AU" term="%22Valenciano+M%22">Valenciano M</searchLink>; Epiconcept, Paris, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22I-MOVE-COVID-19+primary+care+study+team%22">I-MOVE-COVID-19 primary care study team</searchLink>; The members of the I-MOVE-COVID-19 primary care study team are listed in the Investigators tab.<br /><searchLink fieldCode="CA" term="%22I-MOVE-COVID-19+primary+care+study+team+%28in+addition+to+authors+above%29%22">I-MOVE-COVID-19 primary care study team (in addition to authors above)</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100887452%22">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</searchLink> [Euro Surveill] 2021 Jul; Vol. 26 (29). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Centre+for+Disease+Prevention+and+Control+%28ECDC%29%22">European Centre for Disease Prevention and Control (ECDC) </searchLink><i>Country of Publication: </i>Sweden <i>NLM ID: </i>100887452 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1560-7917 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221025496X%22">1025496X </searchLink><i>NLM ISO Abbreviation: </i>Euro Surveill <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34296676 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2807/1560-7917.ES.2021.26.29.2100670 Languages: – Code: eng Text: English Titles: – TitleFull: Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kissling E – PersonEntity: Name: NameFull: Hooiveld M – PersonEntity: Name: NameFull: Sandonis Martín V – PersonEntity: Name: NameFull: Martínez-Baz I – PersonEntity: Name: NameFull: William N – PersonEntity: Name: NameFull: Vilcu AM – PersonEntity: Name: NameFull: Mazagatos C – PersonEntity: Name: NameFull: Domegan L – PersonEntity: Name: NameFull: de Lusignan S – PersonEntity: Name: NameFull: Meijer A – PersonEntity: Name: NameFull: Machado A – PersonEntity: Name: NameFull: Brytting M – PersonEntity: Name: NameFull: Casado I – PersonEntity: Name: NameFull: Murray JK – PersonEntity: Name: NameFull: Belhillil S – PersonEntity: Name: NameFull: Larrauri A – PersonEntity: Name: NameFull: O'Donnell J – PersonEntity: Name: NameFull: Tsang R – PersonEntity: Name: NameFull: de Lange M – PersonEntity: Name: NameFull: Rodrigues AP – PersonEntity: Name: NameFull: Riess M – PersonEntity: Name: NameFull: Castilla J – PersonEntity: Name: NameFull: Hamilton M – PersonEntity: Name: NameFull: Falchi A – PersonEntity: Name: NameFull: Pozo F – PersonEntity: Name: NameFull: Dunford L – PersonEntity: Name: NameFull: Cogdale J – PersonEntity: Name: NameFull: Jansen T – PersonEntity: Name: NameFull: Guiomar R – PersonEntity: Name: NameFull: Enkirch T – PersonEntity: Name: NameFull: Burgui C – PersonEntity: Name: NameFull: Sigerson D – PersonEntity: Name: NameFull: Blanchon T – PersonEntity: Name: NameFull: Martínez Ochoa EM – PersonEntity: Name: NameFull: Connell J – PersonEntity: Name: NameFull: Ellis J – PersonEntity: Name: NameFull: van Gageldonk-Lafeber R – PersonEntity: Name: NameFull: Kislaya I – PersonEntity: Name: NameFull: Rose AM – PersonEntity: Name: NameFull: Valenciano M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2021 Jul Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1560-7917 Numbering: – Type: volume Value: 26 – Type: issue Value: 29 Titles: – TitleFull: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin Type: main |
| ResultId | 1 |
